Predict your next investment

HEALTHCARE | Pharmaceuticals / Drugs
kaipharma.com

See what CB Insights has to offer

Total Raised

$63M

Investors Count

9

Deal Terms

3

KAI Pharmaceuticals Funding, KAI Pharmaceuticals Valuation & KAI Pharmaceuticals Revenue

4 Fundings

KAI Pharmaceuticals's latest funding round was a Acquired for on April 11, 2012.

KAI Pharmaceuticals's valuation in October 2004 was $74.88M.

KAI Pharmaceuticals's latest post-money valuation is from April 2012.

Sign up for a free trial to see KAI Pharmaceuticals's valuations in April 2012 and more.

Date

Round

Amount

Investors

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Revenue

Sources

4/11/2012

Acquired

$99M

5/9/2006

Series B

$99M

0

10/20/2004

Series A

$99M

$74.88M

0

2/24/2003

Seed VC

0

Date

4/11/2012

5/9/2006

10/20/2004

2/24/2003

Round

Acquired

Series B

Series A

Seed VC

Amount

$99M

$99M

Investors

Valuation

$99M

$74.88M

Revenue

Sources

0

0

0

KAI Pharmaceuticals Deal Terms

3 Deal Terms

KAI Pharmaceuticals's deal structure is available for 3 funding rounds, including their Acquired from April 11, 2012.

Round

Acquired

Series B

Series A

Funding Date

$99M

$99M

$99M

Pre-Money Valuation

Post-Money Valuation

$99M

Amount Raised

$99M

$99M

Shares Authorized

Issuance Price

$99M

Dividend Rate

$99M

Liquidation Preferences

$99M

Liquidation Price

Participation

$99M

Conversion Price

Anti Dilution

$99M

General Voting

$99M

$99M

$99M

Board Voting

$99M

$99M

$99M

Par Value

Round

Funding Date

Pre-Money Valuation

Post-Money Valuation

Amount Raised

Shares Authorized

Issuance Price

Dividend Rate

Liquidation Preferences

Liquidation Price

Participation

Conversion Price

Anti Dilution

General Voting

Board Voting

Par Value

Acquired

$99M

$99M

$99M

$99M

Series B

$99M

$99M

$99M

$99M

$99M

$99M

$99M

$99M

$99M

Series A

$99M

$99M

$99M

$99M

KAI Pharmaceuticals Investors

9 Investors

KAI Pharmaceuticals has 9 investors. Amgen invested in KAI Pharmaceuticals's Acquired funding round.

First funding

Last Funding

Investor

Rounds

Board Seats

Type

Location

4/11/2012

4/11/2012

1
Acquired

Corporation

California

00/00/0000

00/00/0000

Skyline Ventures

Subscribe to see more

Venture Capital

California

00/00/0000

00/00/0000

Lumira Ventures

Subscribe to see more

Venture Capital

Canada

00/00/0000

00/00/0000

Thomas Weisel Partners

Subscribe to see more

Investment Bank

New York

00/00/0000

00/00/0000

InterWest Partners

Subscribe to see more

Venture Capital

California

First funding

4/11/2012

00/00/0000

00/00/0000

00/00/0000

00/00/0000

Last Funding

4/11/2012

00/00/0000

00/00/0000

00/00/0000

00/00/0000

Investor

Skyline Ventures

Lumira Ventures

Thomas Weisel Partners

InterWest Partners

Rounds

1
Acquired

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Board Seats

Type

Corporation

Venture Capital

Venture Capital

Investment Bank

Venture Capital

Location

California

California

Canada

New York

California

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.